FDA Inspection 1171682 — ALS Scandinavia AB
The FDA completed an inspection of ALS Scandinavia AB on Feb 9, 2022 in Lulea. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 9, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lulea (Sweden)
Additional details
Mutual Recognition Agreement (MRA)